Understanding Tuberculosis and Why Testing Matters
Tuberculosis, commonly called TB, is an infection caused by bacteria named Mycobacterium tuberculosis. According to the World Health Organization, approximately 10 million people worldwide develop TB each year, with about 1.3 million deaths annually. In the United States, the Centers for Disease Control and Prevention reported approximately 7,352 TB cases in 2022, though this represents a decline from previous decades.
Free Guide to Truck Scales and Certified Weighing →
TB spreads through the air when an infected person coughs, sneezes, or speaks. The bacteria travel in tiny droplets that can be inhaled by others. Not everyone exposed to TB bacteria becomes sick. Some people develop active TB disease, where the bacteria multiply and cause illness. Others develop latent TB infection, meaning the bacteria live in their body but their immune system keeps it under control. People with latent TB cannot spread the disease to others.
Testing is important because it allows doctors and public health professionals to identify who has TB or latent TB infection. Early identification means treatment can begin, preventing serious illness and stopping transmission to others. People at higher risk of TB include those with weakened immune systems, close contacts of TB patients, people with certain medical conditions like diabetes, and individuals from countries where TB is more common.
Understanding your TB status through testing is a key step in protecting your own health and the health of people around you. Different tests exist to detect TB at different stages. Learning about these options helps you understand what a healthcare provider might recommend and why.
Practical Takeaway: TB is a serious but treatable infection. Testing reveals whether you have active TB disease, latent TB infection, or neither. Knowing your status helps guide next steps with your healthcare provider.
The Tuberculin Skin Test (TST) and How It Works
The tuberculin skin test, also known as the Mantoux test or purified protein derivative (PPD) test, is one of the oldest and most widely used TB screening methods. A healthcare worker injects a small amount of PPD—a protein from TB bacteria—just under the skin, usually on the inner forearm. This injection does not contain live bacteria and cannot cause TB infection.
Get Your Free North Carolina DMV Renewal Guide →
The injection itself feels like a tiny pinprick. The PPD solution creates a small raised bump at the injection site immediately after administration, but this bump typically disappears within a few hours. The actual test results depend on what happens over the next 48 to 72 hours. The healthcare provider measures the size of any swelling or induration that develops at the injection site. The measurement is recorded in millimeters, and the size of the reaction determines whether the test is considered positive, negative, or uncertain.
Interpretation of the TST depends on individual risk factors. According to CDC guidelines, different cutoff measurements apply to different populations. For people with no known risk factors, a reaction of 15 millimeters or larger is considered positive. For people at higher risk—such as close contacts of TB cases or people with weakened immune systems—smaller reactions of 5 or 10 millimeters may be considered positive. This variation exists because people at higher risk may have smaller reactions even when infected with TB.
The TST has both advantages and limitations. It is inexpensive, costing approximately $10 to $20, and can be performed in many healthcare settings. However, it requires two visits: one for the injection and another 48 to 72 hours later to read the results. Some vaccines, like the BCG vaccine given in many countries outside the United States, can cause false positive TST results. Additionally, the interpretation can be subjective if the swelling is difficult to measure accurately. People with certain skin conditions or those who have received multiple TSTs over their lifetime may also experience complications with accuracy.
Practical Takeaway: The TST is an inexpensive first-line test but requires two appointments and may show false positives in people who have received certain vaccines. The timing and size of any skin reaction determines the result.
Interferon-Gamma Release Assays (IGRAs) as an Alternative
Interferon-gamma release assays, or IGRAs, represent a newer approach to TB testing compared to the skin test. These blood tests measure how the immune system responds to TB antigens—specific proteins from TB bacteria. When exposed to these antigens in a laboratory setting, white blood cells from people infected with TB produce interferon-gamma, a substance that the test measures. Common IGRA tests include the QuantiFERON test and the T-SPOT.TB test.
Get Your Free United States Vacation Getaway Guide →
The IGRA process involves drawing a small blood sample from a vein, similar to routine blood work. The sample is typically collected in a special tube containing TB antigens. The blood sample is then sent to a laboratory where technicians measure the amount of interferon-gamma produced. Results are usually reported as positive, negative, or indeterminate within 24 hours. Some laboratories can provide results the same day.
IGRAs offer several advantages over skin testing. A single blood draw is all that is needed; there is no return visit required to read results. The test is not affected by prior BCG vaccination, which is important because many people born in other countries received this vaccine and would show false positive skin tests. IGRAs are also less affected by skin conditions that might interfere with skin testing. Additionally, IGRAs have shown good accuracy in detecting both active TB disease and latent TB infection.
However, IGRAs also have limitations. They cost more than skin tests, typically ranging from $50 to $100 or more. The tests may produce indeterminate results in some cases, particularly in people with weakened immune systems or very recent TB exposure. IGRAs require laboratory processing and equipment, so they cannot be performed everywhere a skin test can be done. According to CDC recommendations, IGRAs are preferred for people with prior BCG vaccination and for certain high-risk populations, though skin tests remain an acceptable option in many settings.
Practical Takeaway: IGRAs are blood tests that require one visit and provide results quickly. They are not affected by BCG vaccination but cost more and require laboratory processing.
Chest X-Rays and How They Detect Active TB
When screening tests like the TST or IGRA come back positive, or when a person has symptoms suggesting TB disease, a chest X-ray is typically the next step. A chest X-ray uses radiation to create an image of the lungs and surrounding tissue. Active TB most commonly affects the lungs, and characteristic patterns often appear on X-rays that can suggest TB disease. These patterns may include small white spots, cavities (hollow areas where lung tissue has been destroyed), or areas of consolidation where lung tissue appears solid rather than air-filled.
Learn About Jury Duty Exemptions in Texas →
TB typically appears in the upper lobes of the lungs because TB bacteria prefer areas with higher oxygen levels. The classic appearance of TB on chest X-ray includes cavitary lesions—holes in the lung tissue—which are highly suggestive of active TB. However, other conditions can create similar-looking patterns, so chest X-rays alone cannot definitively diagnose TB. Other infections, old TB that has scarred, fungal infections, or tumors can produce X-ray appearances that resemble TB.
The chest X-ray process is quick and relatively safe. A person stands or sits in front of a machine that takes the image. The procedure takes only a few seconds of actual X-ray exposure. Pregnant women should inform healthcare providers of pregnancy before having X-rays, though the radiation dose from a chest X-ray is considered low risk. The images are typically available within hours, and a radiologist reviews them to describe what is seen.
Chest X-rays serve multiple purposes in TB diagnosis and monitoring. They can suggest whether TB is present and help determine if the disease is active. They also reveal how extensive the infection is and whether it has caused complications. During treatment, repeat X-rays show whether the lungs are healing. However, X-ray findings must be combined with other information, including sputum tests and clinical symptoms, to confirm TB diagnosis. A positive skin test or IGRA with suggestive X-ray findings and TB symptoms strongly suggests active TB, but definitive diagnosis requires identifying the bacteria.
Practical Takeaway: Chest X-rays show lung damage and patterns that may suggest active TB but must be combined with other tests to confirm diagnosis. The procedure is quick with minimal radiation exposure.
Sputum Tests and Bacterial Confirmation
The definitive way to diagnose active TB disease is to identify the TB bacteria itself